XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.2.u1
ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Jan. 06, 2023
Jan. 23, 2024
Jun. 30, 2023
Jun. 15, 2023
Apr. 24, 2023
Mar. 17, 2023
Feb. 28, 2023
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 19, 2018
Allowance for doubtful accounts               $ 19,211,416   $ 19,686,091  
VAT net receivable and payable balance               252,257   187,512  
Long-term liability               398,654   408,665  
Depreciation expense               112,874 $ 65,629    
Amortization expense               89,855 $ 21,058    
Goodwill               49,697   49,697 $ 49,697
National Bank of Greece [Member]                      
Equity method investment aggregate cost               $ 12,100      
Equity method investment shares acquired, shares               16,666      
Closing price               $ 0.73      
Pancreta Bank [Member]                      
Equity method investment aggregate cost               $ 8,271      
Medihelm                      
Sales amount                   397,000  
Cumulative reserve                   12,655,615  
Amount due for receivables                   $ 532,704  
Net receivable balance               $ 456,741      
Building Acquision [Member]                      
Cash $ 3,950,000       $ 1,054,872            
Import/Export License [Member]                      
Estimated Useful Life               5 years      
Pharmaceutical and Nutraceutical Products Licenses [Member]                      
Estimated Useful Life               10 years      
Software [Member]                      
Estimated Useful Life               10 years      
Greece [Member]                      
Intangible assets       $ 425,411              
Cash       $ 109,330              
Shares issued       99,710              
Issuable stock amount       $ 316,081              
CANA Pharmaceutical Laboratories, S.A. ("Cana") [Member]                      
Cash     $ 873,600                
Shares issued     46,377                
Issuable stock amount     $ 138,667         $ 138,667      
Secured Promissory Note             $ 4,457,520        
Asset acquision             $ 5,469,787        
Zip Doctor Inc [Member]                      
Intangible assets           $ 158,788          
Payment in fees           8,788          
Cash           $ 150,000          
Cloudscreen [Member]                      
Cash   $ 317,880                  
Equity method investment shares acquired, shares   280,000                  
Shares of common fair value   $ 319,200                  
Total purchase price amount   637,080                  
Asset acquisition   $ 637,080